Reprinted with Permission from Forbes
by: Helen Coster
I’m in Washington, D.C. as part of a fellowship with the International Reporting Project. Next Saturday I head to Bolivia, where I’ll be reporting and writing on public health and a number of different topics.
One advantage of spending time in D.C.—in addition to meeting other IRP fellows and running past the White House— is the opportunity to meet with the world-class scientists and policy makers who work here. Yesterday I met with Dr. Peter Hotez, the president of the Sabin Vaccine Institute, a non-profit organization that’s affiliated with George Washington University. The Sabin Institute—named after Dr. Albert Sabin, who developed the polio vaccine— develops vaccines for Neglected Tropical Diseases (NTDs), a group of 13 diseases that affect poor people in the developing world. NTDs include diseases like guinea worm, Chagas disease, kala azar and lymphatic filariasis. Together they impact 1.4 billion people, most of whom live on under $1.25 a day. » Read more: A Creative Model for Vaccine Development







